BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 19213202)

  • 1. [Recognition and treatment of behavioral and psychological symptoms of dementias: lessons from the CATIE-AD study].
    Kálmán J; Kálmán S; Pákáski M
    Neuropsychopharmacol Hung; 2008 Oct; 10(4):233-49. PubMed ID: 19213202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.
    Alexopoulos GS; Jeste DV; Chung H; Carpenter D; Ross R; Docherty JP
    Postgrad Med; 2005 Jan; Spec No():6-22. PubMed ID: 17203561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral and psychological symptoms in dementia: the role of atypical antipsychotics.
    Lawlor BA
    J Clin Psychiatry; 2004; 65 Suppl 11():5-10. PubMed ID: 15264965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic strategies for behavioral and psychological symptoms (BPSD) in demented patients.
    Torta R; Badino E; Scalabrino A
    Arch Gerontol Geriatr Suppl; 2004; (9):443-54. PubMed ID: 15207446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of agitation and aggression associated with Alzheimer's disease: controversies and possible solutions.
    Ballard C; Corbett A; Chitramohan R; Aarsland D
    Curr Opin Psychiatry; 2009 Nov; 22(6):532-40. PubMed ID: 19696673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer's disease.
    Lanari A; Amenta F; Silvestrelli G; Tomassoni D; Parnetti L
    Mech Ageing Dev; 2006 Feb; 127(2):158-65. PubMed ID: 16297434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost of behavioral and psychological symptoms of dementia (BPSD) in community dwelling Alzheimer's disease patients.
    Beeri MS; Werner P; Davidson M; Noy S
    Int J Geriatr Psychiatry; 2002 May; 17(5):403-8. PubMed ID: 11994927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia.
    Engelborghs S; Vloeberghs E; Le Bastard N; Van Buggenhout M; Mariën P; Somers N; Nagels G; Pickut BA; De Deyn PP
    Neurochem Int; 2008 May; 52(6):1052-60. PubMed ID: 18093695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caregiver burden associated with behavioral and psychological symptoms of dementia in elderly people in the local community.
    Matsumoto N; Ikeda M; Fukuhara R; Shinagawa S; Ishikawa T; Mori T; Toyota Y; Matsumoto T; Adachi H; Hirono N; Tanabe H
    Dement Geriatr Cogn Disord; 2007; 23(4):219-24. PubMed ID: 17299264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A longitudinal evaluation of behavioural and psychological symptoms of probable Alzheimer's disease.
    Eustace A; Coen R; Walsh C; Cunningham CJ; Walsh JB; Coakley D; Lawlor BA
    Int J Geriatr Psychiatry; 2002 Oct; 17(10):968-73. PubMed ID: 12325059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New therapeutic strategies for behavioral and psychological symptoms of dementia].
    Ikeda M
    Rinsho Shinkeigaku; 2005 Nov; 45(11):861-3. PubMed ID: 16447746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical antipsychotics in the management of behavioral symptoms associated with dementia.
    González-Concepción JJ; Geil K; Jiménez-Velázquez IZ; Ramos-Romey C
    Bol Asoc Med P R; 2009; 101(1):51-3. PubMed ID: 19954089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Trazodone for the treatment of behavioral and psychological symptoms of dementia (BPSD) in Alzheimer's disease: a retrospective study focused on the aggression and negativism in caregiving situations].
    Kitamura Y; Kudo Y; Imamura T
    No To Shinkei; 2006 Jun; 58(6):483-8. PubMed ID: 16856516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral and psychological symptoms assessed with the BEHAVE-AD-FW are differentially associated with cognitive dysfunction in Alzheimer's disease.
    Ito T; Meguro K; Akanuma K; Meguro M; Lee E; Kasuya M; Ishii H; Mori E
    J Clin Neurosci; 2007 Sep; 14(9):850-5. PubMed ID: 17587584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of behavioral disorders in dementia patients].
    Lebert F; Robert P; Rigaud AS
    Rev Neurol (Paris); 2000 Sep; 156(8-9):767-72. PubMed ID: 10992121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risperidone is effective for wandering and disturbed sleep/wake patterns in Alzheimer's disease.
    Meguro K; Meguro M; Tanaka Y; Akanuma K; Yamaguchi K; Itoh M
    J Geriatr Psychiatry Neurol; 2004 Jun; 17(2):61-7. PubMed ID: 15157345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of behavioral and psychological symptoms of dementia: a systematic review.
    Preuss UW; Wong JW; Koller G
    Psychiatr Pol; 2016; 50(4):679-715. PubMed ID: 27847922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with risperidone in the treatment of behavioral and psychological symptoms of dementia.
    Onor ML; Saina M; Trevisiol M; Cristante T; Aguglia E
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):205-9. PubMed ID: 17020789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacological treatment of behavioral symptoms in dementia patients].
    Gabryelewicz T
    Przegl Lek; 2014; 71(4):215-20. PubMed ID: 25141581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality in elderly dementia patients treated with risperidone.
    Haupt M; Cruz-Jentoft A; Jeste D
    J Clin Psychopharmacol; 2006 Dec; 26(6):566-70. PubMed ID: 17110812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.